Dr. Reddy’s Laboratories has informed that the Nomination, Governance and Compensation Committee of the Board of Directors of the Company has approved the allotment of 12,090 equity shares of Rs 5 each underlying 12,090 ADRs pursuant to Dr. Reddy's Employees ADR Stock Option Scheme, 2007 of the Company, fully paid up, on November 6, 2023, to employee(s) pursuant to exercise of Stock Options. Further, the company has enclosed the details as required under Regulation 10(c) of the SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021.
The above information is a part of company’s filings submitted to BSE.
